Talk about a legendary lineup.
Today’s Benzinga Cannabis Capital Conference featured a slate of former NBA stars, each discussing their shared passions for — no, not basketball — cannabis.
Isiah Thomas, John Salley and Al Harrington sat down with Yahoo Finance reporter Alexis Keenan for Monday’s virtual event. The lively discussion wasn’t without jest.
“I haven’t been a THC user like some of my players and teammates,” Thomas said, to which his son, fellow Isiah International co-founder Joshua Thomas, replied with a laugh: “Sitting right next to me.”
But make no mistake: Each of these entrepreneurs take the cannabis industry very seriously, especially when it comes to addressing the role CBD plays in health care, and the social inequities that hinder the sector’s potential in certain markets.
The chairman and CEO of Isiah International LLC did a fine job summarizing what this trio has to offer the space:
“The CBD and CBG oils that we put out really help, not only to control pain and inflammation, which —you know — Al, John and I are familiar with as athletes,” Thomas said. “Pain and inflammation are the things that really hamper you during your play, and after your play, as we all know.”
Thomas was a 12-time NBA All-Star and two-time NBA champion with the Detroit Pistons from 1981-1994.
VESL Oils, which Thomas invested in this year, has a suite of products that encompass an innovative endocannabinoid system that can be used to bolster health in various way, Thomas explained.
“That was really, for myself, very enlightening and all three of …